We identified a G13C mutation in KRAS, a R130Q mutation in PTEN and a mutation in ARID1A. Interestingly, an R93Q mutation in PIK3CA was only detected in the metastatic tumor and the cell line but not in the primary tumor. Here, ARID1A is linked to metastatic neoplasm.